Journal articles on the topic 'BRCA testing'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'BRCA testing.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Parikh, Purvish M., J. Wadhwa, S. Minhas, A. Gupta, S. Mittal, S. Ranjan, P. Mehta, et al. "Practical consensus recommendation on when to do BRCA testing." South Asian Journal of Cancer 07, no. 02 (April 2018): 106. http://dx.doi.org/10.4103/sajc.sajc_112_18.
Full textSahnane, Nora, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro, et al. "BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor." International Journal of Molecular Sciences 21, no. 24 (December 19, 2020): 9708. http://dx.doi.org/10.3390/ijms21249708.
Full textMoore, H. C., R. Wesolowski, T. K. Choueiri, L. Rybicki, A. G. Shealy, G. Casey, and D. Weng. "Therapeutic radiation for breast cancer in BRCA mutation carriers and contralateral breast cancer (CBC) risk." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 611. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.611.
Full textBrankovic-Magic, Mirjana, Jelena Dobricic, Radmila Jankovic, Irene Konstantopoulou, Drakoulis Yannoukakos, and Sinisa Radulovic. "Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?" Archive of Oncology 14, no. 3-4 (2006): 131–35. http://dx.doi.org/10.2298/aoo0604131b.
Full textSchwartz, Zachary Phillip, Mae Zakhour, Andrew John Li, Christine S. Walsh, Bj Rimel, Monica Alvarado, Scott E. Lentz, and Ilana Cass. "Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 1547. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1547.
Full textHolter, Spring, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, et al. "Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma." Journal of Clinical Oncology 33, no. 28 (October 1, 2015): 3124–29. http://dx.doi.org/10.1200/jco.2014.59.7401.
Full textToss, Angela, Eleonora Molinaro, Marta Venturelli, Federica Domati, Luigi Marcheselli, Simonetta Piana, Elena Barbieri, et al. "BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy." Cancers 12, no. 5 (May 15, 2020): 1252. http://dx.doi.org/10.3390/cancers12051252.
Full textShatavi, Seerin Viviane, Lindsay Dohany, Mohammad Muhsin Chisti, Ishmael A. Jaiyesimi, and Dana Zakalik. "Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 1541. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1541.
Full textMatsubara, Nobuaki, Johann S. De Bono, David Olmos, Giuseppe Procopio, Satoru Kawakami, Yuksel Urun, Robbert J. van Alphen, et al. "Olaparib efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC) carrying circulating tumor (ct) DNA alterations in BRCA1, BRCA2 or ATM: Results from the PROfound study." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): 27. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.27.
Full textMurciano-Goroff, Yonina R., Alison M. Schram, Ezra Rosen, Yelena Y. Janjigian, Michael F. Berger, Mark Donoghue, Chaitanya Bandlamudi, and Alexander E. Drilon. "BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 3012. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3012.
Full textSekine, Masayuki, Koji Nishino, and Takayuki Enomoto. "Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location." Genes 12, no. 7 (July 8, 2021): 1050. http://dx.doi.org/10.3390/genes12071050.
Full textRahman, Belinda, Anne Lanceley, Rebecca S. Kristeleit, Jonathan A. Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, and Lucy Side. "Mainstreamed genetic testing for women with ovarian cancer: first-year experience." Journal of Medical Genetics 56, no. 3 (March 13, 2018): 195–98. http://dx.doi.org/10.1136/jmedgenet-2017-105140.
Full textKapoor, Nimmi S., Lisa D. Curcio, Carlee A. Blakemore, Amy K. Bremner, Rachel E. McFarland, John G. West, and Kimberly C. Banks. "Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer." Journal of Clinical Oncology 33, no. 28_suppl (October 1, 2015): 16. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.16.
Full textTrainer, Alison H., Bettina Meiser, Kaaren Watts, Gillian Mitchell, Kathy Tucker, and Michael Friedlander. "Moving Toward Personalized Medicine: Treatment-Focused Genetic Testing of Women Newly Diagnosed With Ovarian Cancer." International Journal of Gynecologic Cancer 20, no. 5 (June 2010): 704–16. http://dx.doi.org/10.1111/igc.0b013e3181dbd1a5.
Full textSalo-Mullen, Erin E., Eileen Mary O'Reilly, David Paul Kelsen, Maeve Aine Lowery, Kenneth H. Yu, Rohini Rau-Murthy, Beth Siegel, et al. "Identification of germline genetic mutations in patients with pancreatic adenocarcinoma." Journal of Clinical Oncology 31, no. 4_suppl (February 1, 2013): 159. http://dx.doi.org/10.1200/jco.2013.31.4_suppl.159.
Full textImyanitov, Yevgeniy, Aleksey Belyaev, Aleksandr Shcherbakov, Lev Bershteyn, Aleksandr Bessonov, Petr Krivorotko, Tatyana Gorodnova, et al. "PRESENCE OF BRCA1 AND BRCA2 IN HEALTHY WOMEN AND MEN: DNA TESTING, DIAGNOSTIC ACTIVITIES AND CANCER PREVENTION." Problems in oncology 63, no. 2 (February 1, 2017): 190–98. http://dx.doi.org/10.37469/0507-3758-2017-63-2-190-198.
Full textJung, J., E. Kang, J. M. Gwak, A. N. Seo, S. Y. Park, A. S. Lee, H. Baek, S. Chae, E. K. Kim, and S. W. Kim. "Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients." Current Oncology 23, no. 5 (October 26, 2016): 298. http://dx.doi.org/10.3747/co.23.3054.
Full textMullai, N. "The importance of variants of unknown significance (VUS) in BRCA mutation." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e22507-e22507. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e22507.
Full textAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi, and Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer." Journal of Clinical Oncology 26, no. 26 (September 10, 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Full textNeveling, Kornelia, Arjen R. Mensenkamp, Ronny Derks, Michael Kwint, Hicham Ouchene, Marloes Steehouwer, Bart van Lier, et al. "BRCA Testing by Single-Molecule Molecular Inversion Probes." Clinical Chemistry 63, no. 2 (February 1, 2017): 503–12. http://dx.doi.org/10.1373/clinchem.2016.263897.
Full textLiu, Ying L., Julia Lindsay Boland, Karen Anne Cadoo, Claire Frances Friedman, Jason A. Konner, Roisin Eilish O'Cearbhaill, Carol Aghajanian, and Dmitriy Zamarin. "Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 2615. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2615.
Full textSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Sukeshi Patel Arora, et al. "Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI)." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 4085. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4085.
Full textOktay, Kutluk, Ja Yeon Kim, David Barad, and Samir N. Babayev. "Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks." Journal of Clinical Oncology 28, no. 2 (January 10, 2010): 240–44. http://dx.doi.org/10.1200/jco.2009.24.2057.
Full textArun, Banu, Angelica Gutierrez Barrera, Rachel M. Layman, Stephen K. Gruschkus, Isabelle Bedrosian, Constance T. Albarracin, Carlos Hernando Barcenas, Vicente Valero, Jennifer Keating Litton, and Debu Tripathy. "Outcome of patients with breast cancer and a germline BRCA mutation in a prospective cohort." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1544. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1544.
Full textAkaev, Iolia, Siavash Rahimi, Olubukola Onifade, Francis John Edward Gardner, David Castells-Rufas, Eleanor Jones, Shyamika Acharige, and Chit Cheng Yeoh. "Tumour Versus Germline BRCA Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom." Diagnostics 11, no. 3 (March 19, 2021): 547. http://dx.doi.org/10.3390/diagnostics11030547.
Full textSmith, Wesley, Kayla Smith, William Sessions, Connor Evins, Michael Baker, and Mary Blumer. "An evaluation of gender discrepancies in genetic referrals for BRCA testing for indicated malignancies." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 10584. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10584.
Full textOktay, K., J. Kim, D. Barad, N. Gleicher, and S. Babayev. "Association of BRCA1 mutations with diminished ovarian reserve: A common genetic mechanism for breast/ovarian cancer, and infertility?" Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 11039. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11039.
Full textMetcalfe, Kelly A., Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun, and Steven A. Narod. "Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women." Journal of Clinical Oncology 28, no. 3 (January 20, 2010): 387–91. http://dx.doi.org/10.1200/jco.2009.25.0712.
Full textLindsey, Heather. "BRCA Testing." Oncology Times 26, no. 3 (February 2004): 12. http://dx.doi.org/10.1097/01.cot.0000291728.63654.be.
Full textMirza, M. A., A. Sehbai, T. Nestor, V. Brown, and J. Abraham. "BRCA mutations: An Appalachian experience." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 20111. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.20111.
Full textPoon, Kok-Siong, Lily Chiu, and Karen Mei-Ling Tan. "Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis." Global Medical Genetics 08, no. 02 (March 16, 2021): 062–68. http://dx.doi.org/10.1055/s-0041-1726338.
Full textHwang, E. Shelley, Jane L. McLennan, Dan H. Moore, Beth B. Crawford, Laura J. Esserman, and John L. Ziegler. "Ductal Carcinoma In Situ in BRCA Mutation Carriers." Journal of Clinical Oncology 25, no. 6 (February 9, 2007): 642–47. http://dx.doi.org/10.1200/jco.2005.04.0345.
Full textKeung, Yi-Kong, Adriana Hu, Annie Yeung, Amy Chan, and Eddie Hu. "Higher prevalence of BRCA2 mutations among Chinese breast cancer patients in a community oncology clinic." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e12017-e12017. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e12017.
Full textRandall, Megan, Kelly Burgess, Lela Buckingham, and Lydia Usha. "Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion." Journal of the National Comprehensive Cancer Network 18, no. 3 (March 2020): 223–28. http://dx.doi.org/10.6004/jnccn.2019.7378.
Full textArun, Banu, Soley Bayraktar, Diane D. Liu, Angelica M. Gutierrez Barrera, Deann Atchley, Lajos Pusztai, Jennifer Keating Litton, et al. "Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience." Journal of Clinical Oncology 29, no. 28 (October 1, 2011): 3739–46. http://dx.doi.org/10.1200/jco.2011.35.2682.
Full textManchanda, Ranjit, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, et al. "Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems." Cancers 12, no. 7 (July 17, 2020): 1929. http://dx.doi.org/10.3390/cancers12071929.
Full textWeitzel, Jeffrey N., Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, et al. "Prevalence and Type ofBRCAMutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network." Journal of Clinical Oncology 31, no. 2 (January 10, 2013): 210–16. http://dx.doi.org/10.1200/jco.2011.41.0027.
Full textHowarth, Dt R., Sharon S. Lum, Pamela Esquivel, Carlos A. Garberoglio, Maheswari Senthil, and Naveenraj L. Solomon. "Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome." American Surgeon 81, no. 10 (October 2015): 941–44. http://dx.doi.org/10.1177/000313481508101006.
Full textChandrasekaran, Dhivya, Monika Sobocan, Oleg Blyuss, Rowan E. Miller, Olivia Evans, Shanthini M. Crusz, Tina Mills-Baldock, et al. "Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study." Cancers 13, no. 17 (August 27, 2021): 4344. http://dx.doi.org/10.3390/cancers13174344.
Full textMetcalfe, Kelly A., Aletta Poll, Andrea Eisen, Jordan Lerner-Ellis, and Steven Narod. "Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 1577. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1577.
Full textAbida, Wassim, David Campbell, Akash Patnaik, Brieuc Sautois, Jeremy David Shapiro, Nicholas J. Vogelzang, Alan Haruo Bryce, et al. "Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)." Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020): 178. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.178.
Full textPal, Tuya, Deborah Cragun, Xuefeng Wang, Sean J. Yoder, Tania MESA, Marilin Rosa, Ann Tezak, Anne Weidner, Susan Thomas Vadaparampil, and Catherine Phelan. "Characterization of germline and tumor genomic profile in unselected young black breast cancer patients." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e13090-e13090. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13090.
Full textBahsi, Taha, and Haktan Bağış Erdem. "Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study." Turkish Journal of Biochemistry 45, no. 1 (December 24, 2019): 83–90. http://dx.doi.org/10.1515/tjb-2019-0424.
Full textGoncalves, Susana Beatriz, Gonzalo Giornelli, Marcelo Horacio Pereira, Dolores Gallardo-Rincon, and Maria Del Pilar Estevez-Diz. "FLABRA, frontline approach for BRCA testing in ovarian cancer (OC) treatment naïve population: A Latin America (LA) epidemiologic study." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e17050-e17050. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e17050.
Full textAbida, Wassim, Alan Haruo Bryce, Nicholas J. Vogelzang, Robert J. Amato, Ivor John Percent, Jeremy David Shapiro, Raymond S. McDermott, et al. "Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 5031. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5031.
Full textToss, Angela, Marta Venturelli, Eleonora Molinaro, Stefania Pipitone, Elena Barbieri, Isabella Marchi, Elena Tenedini, et al. "Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies." Cancers 11, no. 2 (February 7, 2019): 193. http://dx.doi.org/10.3390/cancers11020193.
Full textDi Brino, Eugenio, Matteo Ruggeri, Stefania Boccia, Nicoletta Cerana, Domenica Lorusso, Dario Sacchini, Antonella Savarese, Liliana Varesco, and Americo Cicchetti. "A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer." Global & Regional Health Technology Assessment 7, no. 1 (April 4, 2020): 1–8. http://dx.doi.org/10.33393/grhta.2020.557.
Full textLipton, Joseph H., Mahdi Zargar, Ellen Warner, Ellen E. Greenblatt, Esther Lee, Kelvin K. W. Chan, and William W. L. Wong. "Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations." Human Reproduction 35, no. 2 (February 2020): 434–45. http://dx.doi.org/10.1093/humrep/dez203.
Full textSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony F. Shields, Sukeshi Patel Arora, et al. "Molecular profile of BRCA-mutated biliary tract cancers." ESMO Open 5, no. 3 (June 2020): e000682. http://dx.doi.org/10.1136/esmoopen-2020-000682.
Full textHart, Lowell L., Kai Treuner, Li Ma, Jenna Wong, Catherine A. Schnabel, and James Andrew Reeves. "Integration of molecular cancer classification and next-generation sequencing to identify metastatic patients eligible for PARP inhibitors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e15080-e15080. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15080.
Full text